304 related articles for article (PubMed ID: 23456539)
1. Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine.
Dammacco F; Vacca A; Procaccio P; Ria R; Marech I; Racanelli V
Clin Exp Med; 2013 May; 13(2):85-97. PubMed ID: 23456539
[TBL] [Abstract][Full Text] [Related]
2. Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E; Rocha E
Vasc Health Risk Manag; 2013; 9():207-28. PubMed ID: 23674896
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.
Al-Hameed F; Al-Dorzi HM; AlMomen A; Algahtani F; AlZahrani H; AlSaleh K; AlSheef M; Owaidah T; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schünemann H; Akl EA
Ann Saudi Med; 2015; 35(2):95-106. PubMed ID: 26336014
[TBL] [Abstract][Full Text] [Related]
4. Trousseau's syndrome: cancer-associated thrombosis.
Ikushima S; Ono R; Fukuda K; Sakayori M; Awano N; Kondo K
Jpn J Clin Oncol; 2016 Mar; 46(3):204-8. PubMed ID: 26546690
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years.
Tufano A; Brenner B
Semin Thromb Hemost; 2024 Feb; 50(1):96-103. PubMed ID: 37201536
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
8. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Kahn SR; Lim W; Dunn AS; Cushman M; Dentali F; Akl EA; Cook DJ; Balekian AA; Klein RC; Le H; Schulman S; Murad MH
Chest; 2012 Feb; 141(2 Suppl):e195S-e226S. PubMed ID: 22315261
[TBL] [Abstract][Full Text] [Related]
9. New insights into cancer-associated thrombosis.
Sousou T; Khorana AA
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):316-20. PubMed ID: 19228604
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of oral direct factor Xa inhibitors for the treatment of venous thromboembolism in patients with cancer and/or older age.
Sato D; Ikeda S; Koga S; Yamagata Y; Eguchi M; Yonekura T; Tsuneto A; Yoshimuta T; Koide Y; Kawano H; Maemura K
Heart Vessels; 2019 Apr; 34(4):678-687. PubMed ID: 30341629
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated venous thromboembolism: Burden, mechanisms, and management.
Ay C; Pabinger I; Cohen AT
Thromb Haemost; 2017 Jan; 117(2):219-230. PubMed ID: 27882374
[TBL] [Abstract][Full Text] [Related]
13. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
[TBL] [Abstract][Full Text] [Related]
14. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
Brown A
Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
Giustozzi M; Agnelli G; Del Toro-Cervera J; Klok FA; Rosovsky RP; Martin AC; Herold J; Tzoran I; Szmit S; Bertoletti L; Becattini C; Huisman MV
Thromb Haemost; 2020 Jul; 120(7):1128-1136. PubMed ID: 32365386
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic Risk from Chemotherapy and Other Cancer Therapies.
Debbie Jiang MD; Alfred Ian Lee MD
Cancer Treat Res; 2019; 179():87-101. PubMed ID: 31317482
[TBL] [Abstract][Full Text] [Related]
17. Thromboprophylaxis in non-surgical cancer patients.
Cohen AT; Gurwith MM; Dobromirski M
Thromb Res; 2012 Apr; 129 Suppl 1():S137-45. PubMed ID: 22682125
[TBL] [Abstract][Full Text] [Related]
18. Latest advances in preventing thromboembolic disease in the ambulatory oncology patient.
Maraveyas A
Thromb Res; 2020 Jul; 191 Suppl 1():S91-S98. PubMed ID: 32736786
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
Vedovati MC; Giustozzi M; Becattini C
Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
[TBL] [Abstract][Full Text] [Related]
20. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Frere C; Connors JM; Ay C; Khorana AA; Munoz A; Brenner B; Kakkar A; Rafii H; Solymoss S; Brilhante D; Monreal M; Bounameaux H; Pabinger I; Douketis J;
Lancet Oncol; 2019 Oct; 20(10):e566-e581. PubMed ID: 31492632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]